Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chabot

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
American Journal of Medical Genetics. Part A|July 22, 2004
Osteopathia striata with cranial sclerosis: clinical, radiological, and bone histological findings in an adolescent girlL M Ward, F Rauch, R Travers, et al.
Journal of Chemical Neuroanatomy|April 27, 2000
Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization studyY Tong, J G Chabot, S H Shen, et al.
Leukemia Research|November 1, 1994
Principal drug-metabolizing enzyme systems in L1210 leukemia sensitive or resistant to BCNU in vivoV Ribrag, L Massaad, F Janot, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell deathM Danik, J G Chabot, C Mercier, et al.
Bioorganic & Medicinal Chemistry|February 2, 2013
Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4Nancy Ty, Renée Pontikis, Guy G Chabot, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38L Massaad, G G Chabot, C Toussaint, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinizationM de Forni, G G Chabot, J P Armand, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 26, 2013
Lipidic spherulites: formulation optimisation by paired optical and cryoelectron microscopySylvie Crauste-Manciet, Eric Larquet, Karel Khawand, et al.
Biochemical Pharmacology|August 16, 2011
Fisetin disposition and metabolism in mice: Identification of geraldol as an active metaboliteYasmine S Touil, Nicolas Auzeil, François Boulinguez, et al.
International Journal of Pharmaceutics|March 6, 2012
Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in miceHéloïse Ragelle, Sylvie Crauste-Manciet, Johanne Seguin, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Medical Genetics. Part A|July 22, 2004
Osteopathia striata with cranial sclerosis: clinical, radiological, and bone histological findings in an adolescent girlL M Ward, F Rauch, R Travers, et al.
Journal of Chemical Neuroanatomy|April 27, 2000
Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization studyY Tong, J G Chabot, S H Shen, et al.
Leukemia Research|November 1, 1994
Principal drug-metabolizing enzyme systems in L1210 leukemia sensitive or resistant to BCNU in vivoV Ribrag, L Massaad, F Janot, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell deathM Danik, J G Chabot, C Mercier, et al.
Bioorganic & Medicinal Chemistry|February 2, 2013
Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4Nancy Ty, Renée Pontikis, Guy G Chabot, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38L Massaad, G G Chabot, C Toussaint, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinizationM de Forni, G G Chabot, J P Armand, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 26, 2013
Lipidic spherulites: formulation optimisation by paired optical and cryoelectron microscopySylvie Crauste-Manciet, Eric Larquet, Karel Khawand, et al.
Biochemical Pharmacology|August 16, 2011
Fisetin disposition and metabolism in mice: Identification of geraldol as an active metaboliteYasmine S Touil, Nicolas Auzeil, François Boulinguez, et al.
International Journal of Pharmaceutics|March 6, 2012
Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in miceHéloïse Ragelle, Sylvie Crauste-Manciet, Johanne Seguin, et al.
Pageof 18